title: Correction of severe secondary hyperparathyroidism in two dialysis patients: surgical removal versus percutaneous ethanol injection.
abstract: Two chronic hemodialysis patients had recurrent, severe secondary hyperparathyroidism. The first had no sonographically visible parathyroid gland in the neck. Computed tomography (CT) scan indicated the existence of a parathyroid mass in the upper mediastinum, which was removed surgically. The second patient had two intracervical, hyperplastic parathyroid glands visible on ultrasound examination. He volunteered for nonsurgical removal via sonographically guided percutaneous injection of ethanol. In both patients, serum total calcium concentration decreased dramatically to values near 1.5 mmol/L 24 hours after treatment. In patient 1, serum immunoreactive parathyroid hormone (iPTH) (1-84) decreased from 1,582 pg/mL before surgery to 34 pg/mL after 24 hours (normal range, 10 to 65 pg/mL). In contrast, serum iPTH (1-84) decreased only progressively in patient 2, from 1,680 pg/mL before ethanol injection to 865 pg/mL after 24 hours and to 378 pg/mL after 72 hours to reach 30 pg/mL after 14 days. Thus, patient 2 had a striking decrease of plasma calcium immediately after parathyroid gland destruction, even though circulating iPTH was still very high. The reason for such a discrepancy remains unexplained at present, and further study will be necessary to solve this issue.
authors.affiliation: Département de Néphrologie, Hôpital Necker, Paris, France.
authors.forename: B
authors.initials: B
authors.lastname: Page
authors.forename: J
authors.initials: J
authors.lastname: Zingraff
authors.forename: J C
authors.initials: JC
authors.lastname: Souberbielle
authors.forename: G
authors.initials: G
authors.lastname: Coutris
authors.forename: E
authors.initials: E
authors.lastname: Sarfati
authors.forename: T
authors.initials: T
authors.lastname: Drüeke
authors.forename: J F
authors.initials: JF
authors.lastname: Moreau
mesh_terms: D000328:Adult; D002118:Calcium / Q000097:blood; D000431:Ethanol / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000097:blood / Q000209:etiology / Q000628:therapy*; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood; D016105:Parathyroidectomy; D012008:Recurrence; D006435:Renal Dialysis / Q000009:adverse effects
chemical_list: D010281:Parathyroid Hormone; D000431:Ethanol; D002118:Calcium